Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
02/2010
02/10/2010EP1354896B1 Monoclonal antibody directed against the human bst2 antigen
02/10/2010EP1278546B1 Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents
02/10/2010EP0910655B1 Vaccines for treatment of lymphoma and leukemia
02/10/2010CN101646692A A recombinant mouse-human chimeric Fab against hepatitis b surface antigen
02/10/2010CN101646691A Anti-idiotype monoclonal antibodies as mimotopes of the HIV gp120 antigen
02/10/2010CN101646690A Antibodies to IL-17A
02/10/2010CN101646689A Serum albumin binding proteins with long half-lives
02/10/2010CN101646688A Materials and methods for improved immunoglycoproteins
02/10/2010CN101643732A A gene differentially expressed in breast and bladder cancer and encoded polypeptides
02/10/2010CN101643510A Antibody for recombinant anti CD25 humanized monoclonal antibody
02/10/2010CN101643509A VEGFR-2 resistant monoclonal antibody with human and mouse cross reaction as well as preparation method and application thereof
02/10/2010CN101643508A Single chain antibody of human anti-placenta growth factor
02/10/2010CN101643507A Egg-yolk antibody for resisting soluble egg antigen of Japanese blood flukes, preparation method thereof and application thereof
02/10/2010CN100588662C Cancerous disease modifying antibodies
02/10/2010CN100588660C Antigenic determinant of SARS coronavirus nucleocapsid protein and application thereof
02/09/2010US7659384 Polynucleotides encoding fully human antibodies against human 4-1BB
02/09/2010US7659383 Canine and feline 5T4 polypeptide sequences for use in generating vaccine for prevention and treatment of cell proliferative disorders; veterinary medicine
02/09/2010US7659378 An immunoglobulin heavy chain variable region, an immunoglobulin light chain variable region, together define a single binding site for binding human HGF; neutralizing the activity of HGF
02/09/2010US7659377 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
02/09/2010US7659376 Antibody that binds glyphosate resistance protein
02/09/2010US7659375 Interleukin specific immunoglobulin for prevention and treatment of vision, autoimmune, inflammatory and diabetic disorders
02/09/2010US7659374 Eph receptor Fc variants with enhanced antibody dependent cell-mediated cytotoxicity activity
02/09/2010US7659371 Patched polypeptides and uses related thereto
02/09/2010US7659369 Enzymatic polypeptide for use as diagnostic tool in screening parasiticides
02/09/2010US7659251 Ligand for G-protein coupled receptor FPRL2
02/09/2010US7659116 Monoclonal antibody against frizzled receptor 4
02/09/2010US7659115 Nucleic acid encoding human transductin-1 polypeptide
02/09/2010US7659103 Nucleic acid construct containing fulllength genome of human hepatitis C virus, recombinant fulllength virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus Particle
02/09/2010US7659081 Determination of AM-binding proteins and the association of adrenomedullin (AM) therewith
02/09/2010US7659078 Method and kit for determination of prostacyclin in plasma
02/09/2010US7658934 Chlamydia antigens and protein vaccine
02/09/2010US7658929 Derived from pathogenic microorganisms, useful for vaccination and diagnosis; tuberculosis; detection of CD4+ T lymphocytes recognizing at least one glycopeptide obtained from pathogenic microorganism
02/09/2010US7658925 Human anthrax toxin neutralizing monoclonal antibodies and methods of use thereof
02/09/2010US7658924 Angiopoietin-2 specific binding agents
02/09/2010US7658923 Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26
02/09/2010CA2449488C Compositions and methods for treating hyperimmune response in the eye
02/09/2010CA2404945C Taci as an anti-tumor agent
02/09/2010CA2372666C Methods for predicting pregnancy outcome in a subject by hcg assay
02/09/2010CA2353612C Boron neutron capture therapy using pre-targeting methods
02/09/2010CA2349875C Dna encoding a growth factor specific for epithelial cells
02/09/2010CA2328416C Antibody and use thereof
02/09/2010CA2287469C Interactive system for presenting and eliminating substances
02/09/2010CA2256532C Immunodominant 120 kda surface-exposed adhesion protein genes of ehrlichia chaffeensis
02/04/2010WO2010014629A1 Multi-specific binding proteins targeting b cell disorders
02/04/2010WO2010013836A1 Active targeting type polymeric micelle carrying drug enclosed therein and medicinal composition
02/04/2010WO2010013830A1 Nucleic acid occurring in blood from hepatitis patient, polypeptide encoded by the nucleic acid, and use of the same
02/04/2010WO2010013767A1 Novel protease and use thereof
02/04/2010WO2010013498A1 Therapeutic agent or preventive agent for osteoarthritis
02/04/2010WO2010012911A1 Antibodies binding to adrenomedullin receptors and uses thereof as drugs
02/04/2010WO2009135953A3 Amino acid sequences directed against integrins and uses thereof
02/04/2010WO2009068649A3 Antigen-binding constructs
02/04/2010US20100031398 Genes encoding chavicol/eugenol synthase from the creosote bush larrea tridentata
02/04/2010US20100031378 Novel gene disruptions, compositions and methods relating thereto
02/04/2010US20100031377 Prevention and treatment of synucleinopathic and amyloidogenic disease
02/04/2010US20100029906 Synthetic mimics of mammalian cell surface receptors: method and compositions
02/04/2010US20100029571 Novel and powerful mhc-class ii peptides derived from survivin
02/04/2010US20100029565 RECOMBINANT B. pseudomallei ADHESIN PROTEIN AND METHODS AND USES THEREOF
02/04/2010US20100029497 Method for engineering immunoglobulins
02/04/2010US20100029494 Macromolecular Nucleotide Compounds And Methods For Using The Same
02/04/2010US20100029017 Mono-chlorinated hydroxycoumarin conjugates
02/04/2010US20100029013 Methods for Detecting Asymmetric Dimethylarginine in a Biological Sample
02/04/2010US20100028948 nucleic acids encoding antibodies which immunospecifically bind to one or more respiratory syncytial virus (RSV) antigens
02/04/2010US20100028947 Use of human cells of myeloid leukaemia origin for expression of antibodies
02/04/2010US20100028945 Lactobacillus acidophilus nucleic acid sequences encoding stress-related proteins and uses therefor
02/04/2010US20100028918 Glutaminyl cyclase as a diagnostic/prognostic indicator for neurodegenerative diseases
02/04/2010US20100028907 Novel Antigens and Antibodies Associated to Pancreatic Ductal Adenocarcinoma
02/04/2010US20100028906 Reducing the risk of human anti-human antibodies through v gene manipulation
02/04/2010US20100028901 Method for diagnosing in vitro or ex vivo psychiatric disorders and/or intestinal dysbioses
02/04/2010US20100028882 Methods for diagnosing osteoarthritis
02/04/2010US20100028866 DOPAMINERGIC NEURON PROLIFERATIVE PROGENITOR CELL MARKER Nato3
02/04/2010US20100028559 Method for functionalizing materials and devices comprising such materials
02/04/2010US20100028386 Recombinant p. falciparum merozoite protein-142 vaccine
02/04/2010US20100028374 C-type lectin transmembrane antigen expressed in human prostate cancer and uses therof
02/04/2010US20100028372 Stabilization of aqueous compositions of proteins with displacement buffers
02/04/2010US20100028370 Megalin-based delivery of therapeutic compounds to the brain and other tissues
02/04/2010US20100028368 Sulfide, sulfoxide and sulfone chalcone analogues, derivatives thereof and therapeutic uses thereof
02/04/2010US20100028362 Modulation of t helper cell-mediated immune responses
02/04/2010US20100028359 Antibodies to receptor of advanced glycation end products (rage) and uses thereof
02/04/2010US20100028357 Antibodies That Specifically Bind to Abeta Oligomers and Uses Thereof
02/04/2010US20100028356 Method of diagnosing a neurodegenerative disease
02/04/2010US20100028354 Compositions monovalent for cd28 binding and methods of use
02/04/2010US20100028353 Anti-amyloid immunogenic compositions, methods and uses
02/04/2010US20100028351 Anti-amyloid antibodies, compositions, methods and uses
02/04/2010US20100028349 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity
02/04/2010US20100028347 Antibodies against vascular endothelial growth factor receptor-1
02/04/2010US20100028345 Il-17 receptor a antigen binding proteins
02/04/2010US20100028341 Amino acid sequences that modulate the interaction between cells of the immune system
02/04/2010US20100028340 Antibodies against the rgm a protein and uses thereof
02/04/2010US20100028335 Compositions and Methods to Treat Bone Related Disorders
02/04/2010US20100028330 Methods of upmodulating adaptive immune response using anti-pd1 antibodies
02/04/2010US20100028329 Method for producing glycosylated indole compound and antibody against the compound
02/04/2010US20100028264 Ltbp2 as a biomarker, therapeutic and diagnostic target
02/04/2010CA2732715A1 Treatment agent or preventative agent for osteoarthritis
02/04/2010CA2732574A1 Multi-specific binding proteins targeting b cell disorders
02/04/2010CA2732536A1 Antibodies binding to adrenomedullin receptors and uses thereof as drugs
02/04/2010CA2730015A1 Immunoassay for detection of neurotoxic amino acid associated with neurological disorders
02/03/2010EP2149585A1 Antagonist anti-CD40 monoclonal antibodies and methods for their use
02/03/2010EP2149582A1 Osteopontin functional epitopes, monoclonal antibodies against the epitopes and uses thereof
02/03/2010EP2148929A1 Anti-tissue factor antibodies and compositions with enhanced effector function
02/03/2010EP2148888A1 Humanized antibodies which bind to a (1-42) globulomer and uses thereof
1 ... 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 ... 1494